Hungary to introduce important changes to named patient reimbursement United Arab Emirates: Enacts New Medical Products Law to Boost Innovation in Pharmaceuticals and Medical Devices “What can we learn from 2024’s biotech IPOs?” –  Adam Farlow chats to Fierce Biotech “Failure to prevent fraud”: Baker McKenzie breakfast briefing (15 January 2025) The French Political Crisis Leads the Pharmaceutical and Medical Device Industries Towards A Leap Into the Unknown for 2025